Zandelisib (ME-401) is a PI3K inhibitor that selectively inhibits P110 delta with an IC50 value of 3.5 nM. For details, please refer to compound 1 in patent literature WO2019183226 A1. Zandelisib has antitumor effects.
Molecular Weight:
576.68
Purity:
>99%
CAS Number:
[1401436-95-0]
Formula:
C31H38F2N8O
Target:
PI3K
* VAT and and shipping costs not included. Errors and price changes excepted